Obesity, Insulin Resistance, and Bariatric Surgery

One shared mechanism behind excess weight and type 2 diabetes

Type 2 diabetes and excess weight are not two separate problems that happen to travel together. They share a mechanism. Once you understand that mechanism, a lot of things make sense: why losing weight improves blood sugar, why some diabetes treatments work much faster than others, and why insulin resistance and bariatric surgery so often come up in the same conversation.

This page covers what insulin resistance is, how it is measured, and what the evidence teaches us about reversing it.

How extra weight creates insulin resistance

Insulin signals to your body that it’s time to move sugar out of the bloodstream and into your cells. Insulin resistance is what we call it when your cells stop listening to the insulin signal. Your pancreas tries to compensate for it by sending a louder signal. It releases more and more insulin. It keeps up—for a while. Insulin secretion climbs, and it keeps your blood glucose level near normal. Eventually, the day arrives when the pancreas can no longer keep up. That’s when type 2 diabetes appears.

Adipose tissue (fat) can be a potent driver of insulin resistance, but it depends where it is. Fat stored in the extremities (peripheral fat) is relatively harmless. In contrast, fat associated with your organs—the visceral fat—is very potent, metabolically speaking. It releases free fatty acids and other inflammatory signals that interfere with cells’ receptiveness to the insulin signal. Fat that collects in the liver is especially disruptive of glucose metabolism.

The variable metabolic activity of different kinds of fat is why different people at the same body mass index (BMI) can have very different metabolic health. Location is more important than quantity.

How insulin resistance is measured

We use various tests to understand how well your body is managing blood sugar control. You may recognize them from your chart.

Fasting blood glucose (FBG) and hemoglobin A1C levels (HbA1c) both provide a pretty good idea of your body’s current ability to regulate glucose levels. Both have been used to diagnose type 2 diabetes.

FBG has the benefit of convenience. You get an answer in five seconds, if you have a glucometer. It’s also cheap. You can get a decent glucometer for $30 at Walmart.

The HbA1c test requires sending a tube of blood to the lab, but it lets us determine your average blood glucose level for a period of about three months, which is an immensely useful piece of information. HbA1c recently replaced the glucose tolerance test as the gold standard for diagnosing type 2 diabetes, and it has also become the standard measure of blood sugar control.

The homeostasis model assessment, usually written HOMA-IR, estimates the resistance itself. It combines fasting glucose and fasting insulin into a single number. Researchers rely on it to compare groups at different time points before and after treatment, because it captures a shift in insulin sensitivity that HbA1c alone can miss.

The oral glucose tolerance test measures how fast you clear a sugar load. It tells you something about both insulin resistance and insulin secretion.

What weight loss does

Losing weight reliably improves insulin sensitivity. Reduce visceral fat, and cells begin responding to insulin again. Blood sugars behave.

The amount of weight loss is relevant to the improvement you see. Modest weight loss helps. Significant weight loss helps considerably more. Diet programs that are intensive enough (think six to eight weeks at a weight loss spa or inpatient treatment center) can put type 2 diabetes into remission without any surgery or medication at all.

The problem with travel diet centers is that sooner or later, everybody goes home. Upon return to a normal routine, complete weight regain is the norm. Sustained weight loss is what determines whether diabetes remission lasts.

What weight-loss medications can do

The newer medications, semaglutide and tirzepatide among them, were developed to treat type 2 diabetes before they were ever used for weight alone. They work on two fronts. They help you eat less, and they act directly on glucose metabolism.

In trials, patients lost substantial weight and saw large improvements in blood glucose levels, and many were able to reduce or stop other diabetes medicines. These are ongoing treatments. They work while you take them, and blood sugar tends to drift back up if they are stopped.

Insulin resistance and bariatric surgery: what the trials show

Surgery has been tested head-to-head against medical therapy in randomized controlled trials, which is what makes this evidence unusually strong for a surgical field.

The STAMPEDE trial randomized 150 patients with type 2 diabetes and a BMI of 27 to 43 to one of three arms: intensive medical therapy alone, or that same therapy plus gastric bypass surgery or sleeve gastrectomy. At five years, 29% of the bypass group and 23% of the sleeve group had reached an HbA1c of 6.0% or lower, against 5% of those on medical therapy alone. Weight loss was 23% for bypass, 19% for sleeve, and 5% for medical therapy. Insulin use, triglycerides, HDL cholesterol, and quality-of-life scores all favored surgery.

A separate randomized controlled trial in Rome followed patients for ten years, the longest such data available. Diabetes remission at ten years was 5.5% with medical therapy, 25% after gastric bypass, and 50% after biliopancreatic diversion. Two findings deserve emphasis. Most patients who relapsed still held good glycemic control at ten years. And the surgical groups had dramatically fewer diabetes-related complications than the medically treated group.

Results differ by procedure. Among obese individuals with type 2 diabetes, gastric bypass and sleeve gastrectomy both outperform adjustable gastric banding, which produces less weight loss and a correspondingly weaker metabolic effect.

Why surgery acts faster than weight loss alone

Something happens in the first days after gastric bypass surgery that improves blood sugar before any meaningful weight has come off. Patients often go home on lower insulin doses than they came in with.

Rerouting food changes how and when the gut releases hormones. GLP-1 and PYY rise, ghrelin falls. Those hormones sharpen insulin secretion after meals and blunt appetite. The weight loss that follows then does the slower work of restoring insulin sensitivity. The two effects stack, which is why this field increasingly calls the operations metabolic surgery rather than simply weight-loss surgery.

Remission is not always permanent

Remission is not the same as cure. In the ten-year data above, most patients who reached remission eventually saw blood sugar climb again, though they stayed better controlled than they had been before treatment.

Two things predict durable results. The first is how long you had diabetes before treatment: patients treated earlier, before pancreatic function has declined far, do better. The second is whether the weight stays off. This is why we treat an operation as the start of long-term care rather than the end of treatment.

Who is a candidate

Current guidelines support surgery at a BMI of 35 or higher on weight alone, and at 30 to 34.9 when type 2 diabetes is present. For patients of East Asian descent, those thresholds drop to 32.5 and 27.5.

Our bariatric surgery requirements page covers the full criteria, and our insurance coverage guide explains what the major plans approve.

Obesity and diabetes: frequently asked questions

Can bariatric surgery cure type 2 diabetes?

No. It can put diabetes into remission, sometimes for a decade or more, and it can improve insulin sensitivity dramatically. But remission can end, which is why we keep monitoring your blood sugar for life.

How quickly does blood sugar improve after surgery?

Often within days, well before significant weight has come off. Changes in gut hormone release drive that early effect. The weight loss that follows is what sustains it.

Which operation works best for diabetes?

Gastric bypass has the strongest evidence, with sleeve gastrectomy close behind. Adjustable gastric banding is the weakest of the three, because its metabolic benefit depends almost entirely on how much weight you lose.

Do the weight-loss medications work as well as surgery?

They work well, and for many patients they are the right first step. In head-to-head randomized trials against medical therapy, though, surgery has produced larger and more durable remission rates. The two are not mutually exclusive.

Talk it through with us

If you are living with type 2 diabetes and carrying excess weight, you have more options than you did a decade ago, and better evidence behind them. Request a consultation and we will walk through medication, surgery, and what a combination of the two might look like for you.

References

  1. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes (STAMPEDE). N Engl J Med. 2017;376(7):641-651. doi:10.1056/NEJMoa1600869
  2. Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293-304. doi:10.1016/S0140-6736(20)32649-0

Last updated: